MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-05-02 (massdevice.com)
HistoSonics reportedly eyes sale at $2.5B valuation with Medtronic, GE HealthCare, J&J interest
The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving takeover offers.
Read more
2025-04-11 (law360.com)
Texas : UK : Legal News & Analysis
Legal news and analysis on Texas litigation, policy, deals. Covers lawsuits, regulation, enforcement, legislation, mergers, acquisitions, judicial appointments.
Read more
2025-04-03 (jdsupra.com)
Earnouts in M&A Transactions: Recent Decisions From Delaware | Jones Day - JDSupra
In 2024, Delaware courts issued multiple instructive decisions on earnout provisions in life sciences M&A transactions.
Read more
2025-03-17 (bebeez.it)
The Medtronic giant is bought Bellco.
The USA Medtronic Plc giant won the Emilian Bellco from Charming II funds, Amadeus Capital Partners and Capital Dynamics.
Read more
2025-02-28 (cardiovascularbusiness.com)
Comparing popular TAVR valves | Teleflex to acquire Biotronik assets for $791M | FDA sued over semaglutide | Google's good news | Cardiovascular Business
The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan.
Read more
2025-02-19 (trendlyne.com)
Market closes flat, KIMS signs a 7-year agreement with UAIMS Hospital to provide medical services
Stock market live updates for February 18, 2025. Follow this blog as we add live news and announcements on India's listed companies and the share market.
Read more
2025-02-12 (orthospinenews.com)
Certain Nano Surface Technology Assets Developed by Nanovis Have Been Acquired by Medtronic – Ortho Spine News
Nanovis' FDA-Cleared Nanotechnology is Used to Enhance Medtronic PEEK Interbody Fusion Devices for Use in Spine Surgery
Read more
2025-02-11 (market.us)
Cranial Fixation and Stabilization Devices Market to Grow at 5.6% CAGR
Cranial Fixation and Stabilization Devices Market size is expected to reach USD 4 Bn by 2033, from USD 2.3 Bn in 2023, at a CAGR of 5.6%.
Read more
2025-02-07 (marketbeat.com)
Medtronic plc (NYSE:MDT) Shares Acquired by Ledyard National Bank
Ledyard National Bank raised its position in shares of Medtronic plc (NYSE:MDT - Free Report) by 19.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,393 shares of the medical technology company's stock
Read more
2025-02-06 (rebusinessonline.com)
CBRE Arranges Sale of 1.6 MSF Industrial Portfolio in Metro Atlanta, Memphis -
BRASELTON, GA. AND MEMPHIS, TENN. — CBRE has arranged the sale of a two-property industrial portfolio in Braselton and Memphis totaling more than 1.6 million square feet. The facilities include a 613,440-square-foot cross-dock warehouse in Braselton, a city on the northeast outskirts of the metro Atlanta area, and a 1 million-square-foot cross-dock warehouse in Memphis. The Braselton facility was built in 2016 and is fully leased to a large e-commerce company, and the Memphis property was built in 2021 and is fully occupied by Medtronic. Frank Fallon, Trey Barry, José Lobon, Royce Rose, George Fallon, Ryan Bain, Zach Graham and Bentley Smith of CBRE represented the seller, JW Mitchell Co., in the transaction. The buyer and sales price were not disclosed. Additionally, Brian Linnihan, Mike Ryan, Richard Henry and Taylor Crowder of CBRE’s debt and structured finance team in Atlanta arranged a $69.9 million acquisition loan through Wells Fargo on behalf of the buyer.
Read more
2025-02-05 (globenewswire.com)
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”)...
Read more
2025-01-31 (orthoworld.com)
Stryker and Zimmer Biomet Kick Off 2025 with Strategic Moves |
Stryker divested the majority of its spinal implant business while Zimmer Biomet agreed to acquire foot-and-ankle player Paragon 28.
Read more